Anthem Biosciences Limited IPO

Anthem Biosciences Limited IPO

Mainboard NSE & BSE 100% Book Built Offer
Closed

Price Band

₹540 - ₹570

Total Issue

₹3,395.00 Cr

Bid Dates

14 Jul - 16 Jul

Subscription

63.86x

Est. GMP

₹128 (22.46%)

Website RHP Check Allotment

Tentative Timetable

Open
Close
Allotment
Refunds
Credit
Listing

Business Overview

Anthem Biosciences Limited is a global innovation-led CRDMO (Contract Research, Development and Manufacturing Organization) offering integrated services across the drug development lifecycle. With expertise in both New Chemical Entities (NCEs) and New Biological Entities (NBEs), the company supports biotech and pharma clients through discovery, development, and commercial manufacturing. Its platform spans five modalities—RNAi, ADCs, peptides, lipids, and oligonucleotides—and four manufacturing capabilities: custom synthesis, flow chemistry, fermentation, and biotransformation. Revenue is primarily driven by CRDMO services, with additional income from specialty ingredient sales.

Lot Info

Lot Information for Anthem Biosciences IPO
Category Lots Shares Amount
Retail (Min) 1 26 ₹14,820
Retail (Max) 13 338 ₹1,92,660
S-HNI (Min) 14 364 ₹2,07,480
S-HNI (Max) 67 1,742 ₹9,92,940
B-HNI (Min) 68 1,768 ₹10,07,760

Category Reservation

QIB 50%
NII 15%
Ret 35%
Employee
TBT
Shareholder
₹0.00

Issue Size

Total ₹3,395.00 Cr
Fresh Issue
₹0.00 (0.00 Shares)
Offer For Sale
₹3,395.00 Cr (5.96 Cr Shares)

Objects of Issue

The issue is a complete Offer for Sale (OFS). The company will not receive any funds from the issue, entire proceeds will be received by the Selling Shareholder(s).

Selling Shareholders:

  • Ganesh Sambasivam (Promoter): 350 Cr
  • K Ravindra Chandrappa (Promoter): 350 Cr
  • Viridity Tone LLP (Investor): 1,325 Cr
  • Portsmouth Technologies LLC (Investor): 320 Cr
  • Others: 1,050 Cr

Grey Market Premium

GMP ₹128
Est. Price ₹698
Est. Gain 22.46%

Anthem Biosciences IPO Peer Comparison

(Rs. in crores)

Anthem Biosciences IPO Peer Comparison Table
Particulars Anthem Biosciences Syngene International Sai Life Sciences Cohance Life sciences Divi’s Laboratories
Revenue from Ops (in Crs.) 1,844.55 3,642.40 1,694.57 1,197.58 9,360.00
PAT (In Crs.) 451.26 496.20 170.13 264.77 2,191.00
EPS - Basic 8.07 12.35 8.83 10.52 82.53
NAV per share 43.10 117.42 102.12 72.31 564.87
RONW 20.82% 11.05% 10.96% 13.61% 15.35%
EBITDA 36.81% 28.60% 23.94% 31.33% 31.71%
PAT Margin 23.38% 13.36% 9.83% 21.08% 22.56%
Price to earning (PE) 70.63 51.54 92.18 97.29 83.22
  • All information pertains to FY 2024-25.
  • The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of July 7, 2025 for Peers

Financial Performance

(Rs. in crores)

Financial Performance Metrics for Anthem Biosciences IPO
Particulars Mar-25 Mar-24 Mar-23
Revenue from Operations 1,844.55 1,419.37 1,056.92
Profit after Tax 450.86 367.06 385.94
Net Worth 2,409.86 1,924.66 1,740.67
Total Borrowing 108.95 232.53 125.06
Total Assets 2,807.58 2,398.11 2,014.46
NAV per share (in ₹) 43.10 34.43 30.51
EPS - Basic (in ₹) 8.07 6.48 6.75

KPIs

EBITDA

36.81%

PAT

23.38%

ROE

20.82%

PE Ratio

70.63

PB Ratio

13.23

Mkt Cap (in Crs.)

32,011.77

  • All the data pertains to FY 2024-25.
  • PE, PB, and market capitalization are calculated based on the Upper Price Band.

Shareholding

Promoter

76.88%

Public

23.12%

Ajay Bhardwaj 42.53%
Ishaan Bhardwaj 10.16%
Ganesh Sambasivam 9.23%
K Chandrappa 8.86%
Other Promter 6.10%

Management

Ajay Bhardwaj Chairman , MD & CEO
Mohammed Baig CFO

Registrar & Lead Managers

Subscription Status

Updated as on 16-Jul-2025 19:00:00

Mainboard Subscription Status for Anthem Biosciences IPO
Category Sub (x) Offered Bids
QIB 192.80 1,18,83,334 2,29,10,95,976
NII 44.71 89,12,500 39,84,69,578
bHNI 51.66 59,41,667 30,69,18,534
sHNI 30.82 29,70,833 9,15,51,044
Retail 5.96 2,07,95,833 12,38,47,828
Employee 7.00 1,58,654 11,10,746
Total 67.41 4,17,50,321 2,81,45,24,128

Frequently Asked Questions

What is Anthem Biosciences IPO?
Anthem Biosciences IPO is a Mainboard IPO having an issue size of ₹3,395.00 Crs. Anthem Biosciences IPO is priced at ₹540 - ₹570 per share. The issue opens on 14 Jul 25 and closes on 16 Jul 25.
When will Anthem Biosciences IPO open?
Anthem Biosciences IPO opens on 14 Jul 25 and closes on 16 Jul 25.
What is the GMP of Anthem Biosciences IPO?
The estimated Grey Market Premium of Anthem Biosciences IPO is ₹128 per share (22.46%).
What is the lot size of Anthem Biosciences IPO?
The minimum lot size of Anthem Biosciences IPO is 26 shares & the minimum application amount is Rs. 14820.
When is the allotment of Anthem Biosciences IPO?
The allotment date of Anthem Biosciences IPO is 17 Jul 25.
What is the listing date of Anthem Biosciences IPO?
The listing date of Anthem Biosciences IPO is 21 Jul 25.
What is the subscription of Anthem Biosciences IPO?
Anthem Biosciences IPO is subscribed 63.86 times.
What is the price band of Anthem Biosciences IPO?
Anthem Biosciences IPO is priced at ₹540 - ₹570 per share.
How to check allotment status of Anthem Biosciences IPO?
Click the allotment link on Anthem Biosciences IPO page of IPO360.
How to apply Anthem Biosciences IPO in Zerodha?
  1. Go to Kite App → Tap on Bids → Tap on IPO
  2. Select the IPO → Tap on apply → Enter UPI ID
  3. Enter Qty and Price
  4. Submit the application
  5. Approve the UPI Mandate on your UPI app
How to apply Anthem Biosciences IPO in Groww?
  1. Go to Groww App → Stocks Section → Select IPO option
  2. Select the IPO you want to apply
  3. Enter your bid details and price
  4. Enter UPI ID & submit
  5. Approve the UPI Mandate on your UPI app
How to apply Anthem Biosciences IPO using ASBA?
  1. Log in to your bank's net banking portal.
  2. Navigate to the 'IPO' or 'ASBA' section.
  3. Select Anthem Biosciences IPO from the list of available IPOs.
  4. Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
  5. Submit the application.
  6. Money will remain blocked till the refund date